BIOMAT Database Logo BIOMAT Database Logo

Asymmetrical pupillary slowing and degree of severity in myasthenia gravis. 1980

R C Bryant

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011680 Pupil The aperture in the iris through which light passes. Pupils
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R C Bryant
[Pupillary involvement in myasthenia gravis].
January 1971, Shinkei kenkyu no shimpo. Advances in neurological sciences,
R C Bryant
Pupillary dysfunction in myasthenia gravis.
July 1979, Annals of neurology,
R C Bryant
Pupillary fatigue in myasthenia gravis.
January 1982, Transactions of the ophthalmological societies of the United Kingdom,
R C Bryant
Myasthenia gravis with pupillary involvement.
January 1995, Eye (London, England),
R C Bryant
Pupillary abnormalities in myasthenia gravis. Report of a case.
March 1961, Neurology,
R C Bryant
Abnormal pupillary responses in myasthenia gravis. A pupillographic study.
August 1976, The British journal of ophthalmology,
R C Bryant
Myasthenia gravis: disease severity and prognosis.
January 2006, Acta neurologica Scandinavica. Supplementum,
R C Bryant
Seronegative myasthenia gravis: disease severity and prognosis.
June 2005, European journal of neurology,
R C Bryant
The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
August 2004, Journal of neurology,
R C Bryant
Myasthenia gravis-treatment and severity in nationwide cohort.
April 2022, Acta neurologica Scandinavica,
Copied contents to your clipboard!